China’s Abrupt Covid Pivot Leaves Many Without Medicinesnews2022-12-20T10:30:40+00:00December 20th, 2022|The New York Times|
They Created a Drug for Susannah. What About Millions of Other Patients?news2022-12-19T22:40:09+00:00December 19th, 2022|The New York Times|
Cold and Flu Medicine: What to Stock for the ‘Tripledemic’news2022-12-17T10:00:23+00:00December 17th, 2022|The New York Times|
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?news2022-12-16T10:00:26+00:00December 16th, 2022|The New York Times|
Los bloqueadores de pubertad pueden ayudar a menores trans. ¿A qué costo?news2022-12-14T14:30:22+00:00December 14th, 2022|The New York Times|
As Covid Spreads Fast in China, Beijing Isn’t in Lockdown. But It Feels Like It.news2022-12-13T12:27:12+00:00December 13th, 2022|The New York Times|
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?news2022-12-06T20:59:36+00:00December 6th, 2022|The New York Times|
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trialnews2022-12-02T21:55:07+00:00December 2nd, 2022|The New York Times|
Alzheimer’s Drug May Benefit Some Patients, New Data Showsnews2022-11-30T00:50:06+00:00November 30th, 2022|The New York Times|
Flu and R.S.V. Increase Demand for Antibiotics and Antiviralsnews2022-11-23T21:27:44+00:00November 23rd, 2022|The New York Times|
